Researchers at Children’s Hospital of Philadelphia evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder.
Researchers at Children’s Hospital of Philadelphia evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
